This post was originally published on News-medical.net
You will shortly be re-directed to the publisher's website
Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, that are being simultaneously presented at the American Heart Association’s 2024 Scientific Sessions.